Baseline review: 16 needlestick injuries over three years pre-intervention (8 in 1994, 3 in 1995, 5 in 1996) prompted a facility-wide project despite relatively low injection volume per injury.
Root causes: Injuries traced to two-handed blood-draw devices/procedures, manual safety (sheathing) IM syringes, overfilled/opaque sharps containers, and contaminated container designs that exposed needles.
Blood-draw devices: A manual needle covering device sets (implicated in injuries) was first replaced by blunting technology, then by retractable blood-draw devices (spring-action needle retraction, one-hand activation), making post-use needlestick nearly impossible.
Sharps containers: Opaque containers that encouraged overfilling were replaced with translucent letter-drop models so staff could see fill level and avoid exposure. Policy set replacement at three-quarters full.
Injection syringes: Manual safety (sheathing) IM syringes (linked to injuries) were replaced with retractable syringes that automatically retract upon full plunger depression, eliminating the need for two-handed actions.
Cost savings: Although retractable syringes appeared costlier at first glance, analysis showed $0.45 savings per injection with the retractable product.
IV safety: The facility also adopted safer IV catheter systems as part of a comprehensive device update.
Policy & monitoring: Leadership monitored for recapping/bending/breaking needles and enforced container replacement at ≤¾ full to sustain safe practices.
Outcome: After interventions, zero needlestick injuries for two consecutive years (confirmed by follow-up and surveillance).